What other etiologies could explain chronic constipation in a patient who developed it before starting amlodipine?

Chronic Constipation Before Amlodipine: Alternative Etiologies

The patient's chronic constipation preceded amlodipine initiation, so you must systematically evaluate metabolic, neurologic, structural, and medication-related causes before attributing symptoms to the calcium channel blocker. 1

---

Primary Differential Diagnosis to Exclude

Metabolic and Endocrine Disorders

• Hypothyroidism, hypercalcemia, hypokalemia, uraemia, and diabetes mellitus are established metabolic contributors to constipation and should be screened when clinically indicated 1
• Order thyroid-stimulating hormone (TSH), serum calcium, and glucose only if other clinical features suggest these disorders—routine metabolic panels are not recommended in uncomplicated constipation 1
• Dehydration, particularly in older adults, is a common reversible cause 1

Neurologic Conditions

• Parkinson's disease, spinal cord lesions or compression, autonomic neuropathy, and myopathy impair colonic motility 1
• Perform a focused neurologic examination looking for bradykinesia, rigidity, sensory deficits, or abnormal reflexes 1

Structural and Colonic Diseases

• Colonic strictures, colorectal cancer, anal fissure, proctitis, rectal prolapse, and radiation-induced fibrosis can cause mechanical obstruction 1
• Digital rectal examination (DRE) is mandatory to assess for high anal resting tone, paradoxical puborectalis contraction, palpable masses, fecal impaction, or reduced perineal descent 1
• Order colonoscopy only if alarm features are present: rectal bleeding, anemia, unintentional weight loss, or sudden symptom onset 1

Medication-Induced Constipation (Non-CCB)

• Opioids cause opioid-induced constipation (OIC), a distinct Rome IV entity defined as "constipation triggered or worsened by opioid analgesics" 1
• Anticholinergics (e.g., antihistamines, tricyclic antidepressants, bladder antimuscarinics) reduce colonic motility 1
• Iron supplements, 5-HT₃-antagonist antiemetics (ondansetron), vinca-alkaloid chemotherapy, and antidepressants are recognized pharmacologic contributors 1
• Review the complete medication list before attributing constipation to amlodipine 1

---

Functional Constipation Subtypes

Defecatory Disorders (Pelvic Floor Dysfunction)

• Prolonged straining with soft stools, need for digital evacuation, or manual perineal/vaginal pressure are pathognomonic for dyssynergic defecation 1
• Sensation of incomplete evacuation despite soft stool strongly suggests outlet obstruction rather than slow transit 1
• DRE findings: high resting tone, paradoxical puborectalis contraction during simulated defecation, or inability to expel the examiner's finger 1
• Anorectal manometry with balloon expulsion test is the essential first-line diagnostic work-up; failure to expel a 50 mL balloon within 1–3 minutes confirms dyssynergia 1
• Biofeedback therapy is the definitive first-line treatment (Grade A recommendation, 70–80% success rate) 1

Slow Transit Constipation (STC)

• Characterized by infrequent bowel movements (< 3 per week), reduced colonic propulsive activity, and normal anorectal function 1
• Colonic transit study should be performed only after excluding defecatory disorders, as secondary slow transit improves once pelvic floor dysfunction is treated 2
• First-line therapy: polyethylene glycol (PEG) 17 g daily plus bisacodyl 10 mg once daily 2
• Second-line: prucalopride 2 mg once daily if laxatives fail 2

Normal Transit Constipation (NTC)

• Normal colonic transit with normal anorectal function, often associated with irritable bowel syndrome features (abdominal pain, bloating unrelated to defecation) 1
• Treat with fiber supplementation (20–25 g/day, preferably soluble fiber like psyllium), adequate hydration (≥ 1.5 L/day), and osmotic laxatives 2

---

Structured Diagnostic Algorithm

Step 1: History and Physical Examination

• Symptom pattern: Infrequency alone suggests NTC or STC; straining with soft stools indicates defecatory disorder 1
• Medication review: Identify opioids, anticholinergics, iron, and other constipating agents 1
• Alarm features: Blood in stools, anemia, unintentional weight loss, sudden onset mandate colonoscopy 1
• DRE: Assess resting tone, puborectalis contraction, perineal descent, and ability to expel finger 1

Step 2: Laboratory Testing

• Complete blood count (CBC) is the only routine test required to exclude anemia 1
• Metabolic panels (glucose, calcium, TSH) are ordered only if systemic symptoms suggest endocrine or metabolic disease 1

Step 3: Anorectal Testing (Before Imaging)

• Anorectal manometry + balloon expulsion test is mandatory when history or DRE suggests defecatory disorder 1
• Do not order colonic transit studies first—up to 30% of patients have secondary slow transit from untreated dyssynergia 1

Step 4: Colonoscopy (Selective)

• Perform only if alarm features are present or age-appropriate colorectal cancer screening is overdue 1
• Do not repeat colonoscopy if a recent normal study exists and no new alarm features have developed 1

Step 5: Colonic Transit Study (Third-Line)

• Order only after normal anorectal testing or failed biofeedback therapy 1
• Identifies true slow transit constipation requiring prokinetic therapy 2

---

Common Pitfalls to Avoid

• Do not assume amlodipine is the cause when constipation preceded its initiation—systematically exclude other etiologies first 1
• Do not order routine metabolic panels in the absence of systemic symptoms; the diagnostic yield is extremely low 1
• Do not perform colonoscopy in young patients without alarm features 1
• Do not skip anorectal testing when defecatory disorder is suspected—unrecognized dyssynergia leads to failed medical therapy and unnecessary surgical interventions 1
• Do not prescribe high-dose fiber before ensuring adequate hydration and excluding outlet obstruction, as it worsens symptoms in defecatory disorders 1
• Do not attribute constipation to irritable bowel syndrome without first excluding a defecatory disorder, as the two conditions overlap in ~30% of cases but require different therapies 1

---

When to Refer

• Gastroenterology or pelvic floor specialist: For anorectal manometry, balloon expulsion testing, and biofeedback therapy when defecatory disorder is suspected or confirmed 1
• Colorectal surgery: When defecography reveals structural pelvic floor abnormalities (e.g., large rectocele, rectal prolapse) requiring repair 1
• Failure to respond to over-the-counter laxatives and fiber supplementation after 1–2 weeks 1